An adjuvant compound that enhances immunogenicity at fractional doses of the Sabin‐inactivated poliovirus vaccine (sIPV) with a long duration of protection in a rat model
- 9 October 2018
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 91 (1) , 14-21
Abstract
Background: At the same dosage, the new generation of Sabin‐inactivated poliovirus vaccine (sIPV) is less immunogenic than the traditional oral polio vaccine (OPV) dosage in China. The useful adjuvant might be a necessary strategy to strengthen the immune protective effects.Methods: In this study, we produced an adjuvant compound (named KML05) that could promote immunogenicity and fractional doses of sIPV with a long duration of protection in a rat model. The compound adjuvant had both advantages and a function of MF59 and carbopol971P.Results: The effect seroconversion of experimental animals immunized with KML05 could be extended to one‐eighth of the dose. According to the result of the geometric mean titers (GMTs), KML05 adjuvant could save eight times the amount of sIPV D‐antigen usage, but aluminum hydroxide adjuvant could save twice at the same titers. Additionally, it was found that there was a significant difference in the GMT titer of poliovirus type 2 between animals immunized by KML05 and alum adjuvant (P < 0.05). At 12th‐month postvaccination, the neutralization titers stimulated by IPV‐KML05 were maintained over a longer time period in immunized animals.Conclusion: Our research team developed KML05 adjuvant, which combined carbopol971P with MF59, increased antibody responses to sIPV for a longer duration of protection in a rat model.Keywords
Funding Information
- International cooperation project (2011DFR30420)
- Medical Science and Technology Innovation Project of Chinese Academy of Medical Sciences (2016-I2M-3-026)
- National Science and Technology Major Project (2013ZX10004003-003-002)
- Innovation team in Yunnan Province (2015HC027)
- Scientific Research Projects of Health Care (200802023)
This publication has 19 references indexed in Scilit:
- The polio endgame: securing a world free of all poliovirusesThe Lancet, 2018
- Polio vaccines: WHO position paper, March 2016–recommendationsVaccine, 2017
- Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunizationPublic Health, 2017
- Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating VaccinesPLOS Pathogens, 2016
- Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in ratsHuman Vaccines & Immunotherapeutics, 2016
- A mucosal adjuvant for the inactivated poliovirus vaccineVaccine, 2014
- Safety and Immunogenicity of Inactivated Poliovirus Vaccine Made From Sabin Strains: A Phase II, Randomized, Positive-Controlled TrialThe Journal of Infectious Diseases, 2011
- Characterization and standardization of Sabin based inactivated polio vaccine: Proposal for a new antigen unit for inactivated polio vaccinesVaccine, 2011
- From Emergence to Eradication: The Epidemiology of Poliomyelitis DeconstructedAmerican Journal of Epidemiology, 2010
- Some Observations on Poliomyelitis Lameness SurveysClinical Infectious Diseases, 1984